LCM
AGN

Lakewood Capital Management’s Allergan plc AGN Stock Holding History

Lakewood Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-140,823
Closed -$23M – 41
2017
Q4 		$23M Buy
+140,823
New +$25.3M 0.8% 28
2016
Q4 		– Sell
-255,400
Closed -$58.8M – 44
2016
Q3 		$58.8M Buy
+255,400
New +$62.4M 1.33% 17
2016
Q2 		– Sell
-441,382
Closed -$118M – 36
2016
Q1 		$118M Buy
441,382
+37,000
+9% +$10.6M 5.15% 9
2015
Q4 		$126M Buy
404,382
+192,990
+91% +$57.5M 5.47% 8
2015
Q3 		$57.5M Buy
211,392
+102,259
+94% +$31.4M 2.17% 19
2015
Q2 		$33.1M Buy
+109,133
New +$32.5M 1.37% 25

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Lakewood Capital Management's AGN Position: Q1 2018 in Review

Lakewood Capital Management sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 140,823 shares — an estimated $23M sold.

Lakewood Capital Management first reported a position in AGN in Q2 2015 and held it in 6 quarters. The position peaked at $126M in Q4 2015. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Lakewood Capital Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Lakewood Capital Management sold 140,823 Allergan plc shares in Q1 2018, an estimated $23M.
  • Lakewood Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 6 quarters.
  • Lakewood Capital Management's Allergan plc position peaked at $126M in Q4 2015.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Lakewood Capital Management's 13F filing for Q1 2018, filed 15 May 2018.